Catalyst
Slingshot members are tracking this event:
Immune Design (IMDZ) to present preliminary data from CMB305 Phase 1 single arm study in soft tissue sarcoma patients at ASCO 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| IMDZ |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jun 05, 2016
Occurred Source:
http://www.immunedesign.com/wp-content/uploads/2016/06/LV305-ASCO-poster-2016-final-31May2016-v01.pdf
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Cmb305, Phase 1 Data, Single Arm Study, Sarcoma, Asco 2016
